• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非专科医生药物过敏教育课程的影响:ADAPT-A随机交叉试验的结果

Impact of a drug allergy education course for non-specialists: Findings from ADAPT-A randomized crossover trial.

作者信息

Lucas Michaela, Mak Hugo W F, Lee Jasmine T Y, Kulkarni Rishabh, Chan Sophia S C, Li Philip H

机构信息

Immunology Department, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.

Medical School, University of Western Australia, Perth, Western Australia, Australia.

出版信息

Allergy. 2025 Feb;80(2):525-533. doi: 10.1111/all.16270. Epub 2024 Aug 7.

DOI:10.1111/all.16270
PMID:39109415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11804302/
Abstract

BACKGROUND

The consequences of drug allergy remain a global health concern. Drug allergy is often a neglected topic and many non-specialists lack sufficient knowledge or confidence in evaluating or managing this common condition. Evidence-based interventions to better equip non-specialists to tackle drug allergy are needed. The aim of the study is to evaluate the effectiveness of an intensive educational course on drug allergy knowledge and practice of non-specialists.

METHODS

A randomized crossover trial (NCT06399601) was conducted among practicing physicians and nurses participating in an intensive drug allergy course-Advances in Drug Allergy & Penicillin Testing (ADAPT). Participants' baseline knowledge and self-reported practices were assessed with standardized questionnaires (scored from 0 to 100, with "satisfactory" defined as ≥60/100). Participants were randomized into two cohorts and attended ADAPT at different time points. Serial responses before and after the course were compared within and between cohorts.

RESULTS

Seventy participants (25 physicians, 45 nurses) randomized into two groups completed the course. Baseline drug allergy knowledge (58.0 ± 19.9) and self-reported practice (36.9 ± 24.3) were unsatisfactory among non-specialists, with significantly lower scores from nurses than physicians in both domains (knowledge: 49.0 ± 17.4 vs. 74.0 ± 12.7; practice: 32.1 ± 21.3 vs. 53.3 ± 23.1; all p < 0.001). Following completion of ADAPT, participants demonstrated significant improvements in knowledge (58.0 ± 19.9 vs. 77.7 ± 15.9, p < 0.001) and self-reported practice (36.9 ± 24.3 vs. 71.0 ± 20.2, p < 0.001). All participants (100%) and 99% of participants agreed that the course improved their clinical knowledge and practice, respectively.

CONCLUSIONS

ADAPT, an intensive drug allergy educational course was effective in improving drug allergy knowledge and practice for non-specialists. Further longitudinal studies are required to evaluate long-term impact.

摘要

背景

药物过敏的后果仍是全球关注的健康问题。药物过敏往往是一个被忽视的话题,许多非专科医生在评估或处理这种常见病症时缺乏足够的知识或信心。需要有循证干预措施,以使非专科医生更好地应对药物过敏。本研究的目的是评估一门强化教育课程对非专科医生药物过敏知识及实践的有效性。

方法

在参加强化药物过敏课程——药物过敏与青霉素检测进展(ADAPT)的执业医生和护士中进行了一项随机交叉试验(NCT06399601)。通过标准化问卷评估参与者的基线知识和自我报告的实践情况(评分范围为0至100,“满意”定义为≥60/100)。参与者被随机分为两组,并在不同时间点参加ADAPT课程。比较两组内及两组间课程前后的系列反应。

结果

随机分为两组的70名参与者(25名医生,45名护士)完成了课程。非专科医生的基线药物过敏知识(58.0±19.9)和自我报告的实践情况(36.9±24.3)不理想,在这两个方面护士的得分均显著低于医生(知识:49.0±17.4对74.0±12.7;实践:32.1±21.3对53.3±23.1;所有p<0.001)。完成ADAPT课程后,参与者在知识(58.0±19.9对77.7±15.9,p<0.001)和自我报告的实践情况(36.9±24.3对71.0±20.2,p<0.001)方面有显著改善。所有参与者(100%)和99%的参与者分别认为该课程提高了他们的临床知识和实践能力。

结论

ADAPT这门强化药物过敏教育课程对提高非专科医生的药物过敏知识及实践有效。需要进一步进行纵向研究以评估长期影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4191/11804302/0776d5d9be7b/ALL-80-525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4191/11804302/87b6efb72b90/ALL-80-525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4191/11804302/8cb5f9033490/ALL-80-525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4191/11804302/0776d5d9be7b/ALL-80-525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4191/11804302/87b6efb72b90/ALL-80-525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4191/11804302/8cb5f9033490/ALL-80-525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4191/11804302/0776d5d9be7b/ALL-80-525-g001.jpg

相似文献

1
Impact of a drug allergy education course for non-specialists: Findings from ADAPT-A randomized crossover trial.非专科医生药物过敏教育课程的影响:ADAPT-A随机交叉试验的结果
Allergy. 2025 Feb;80(2):525-533. doi: 10.1111/all.16270. Epub 2024 Aug 7.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Direct oral penicillin challenge in secondary care with low-risk patients: the SPACE mixed-methods study with cost-effectiveness analysis.二级医疗中对低风险患者进行直接口服青霉素激发试验:SPACE混合方法研究及成本效益分析
Health Soc Care Deliv Res. 2025 Apr;13(9):1-96. doi: 10.3310/MTYW6557.
4
Survey of Obstetric Providers to Assess the Knowledge and Management of a Reported Penicillin Allergy in Pregnant Women.评估产科医务人员对报告的孕妇青霉素过敏的知识和管理情况的调查。
Am J Perinatol. 2023 Jan;40(1):1-8. doi: 10.1055/a-1877-9970. Epub 2022 Jun 16.
5
HIV Pre-exposure Prophylaxis (PrEP): Knowledge, attitudes and counseling practices among physicians in Germany - A cross-sectional survey.HIV 暴露前预防(PrEP):德国医生的知识、态度和咨询实践 - 一项横断面调查。
PLoS One. 2021 Apr 29;16(4):e0250895. doi: 10.1371/journal.pone.0250895. eCollection 2021.
6
Prospective, Multicenter, Head-to-Head Comparison Between Allergists Versus Nonallergists in Low-Risk Penicillin Allergy Delabeling: Effectiveness, Safety, and Quality of Life (HK-DADI2).前瞻性、多中心、过敏专科医生与非过敏专科医生在低风险青霉素过敏脱标签治疗中的头对头比较:有效性、安全性和生活质量(HK-DADI2)。
J Allergy Clin Immunol Pract. 2024 Jul;12(7):1801-1808.e2. doi: 10.1016/j.jaip.2024.04.010. Epub 2024 Apr 16.
7
A survey of inpatient practitioner knowledge of penicillin allergy at 2 community teaching hospitals.对两家社区教学医院住院医生青霉素过敏知识的一项调查。
Ann Allergy Asthma Immunol. 2017 Jul;119(1):42-47. doi: 10.1016/j.anai.2017.04.023. Epub 2017 May 20.
8
Penicillin allergy SHACK: Survey of hospital and community knowledge.青霉素过敏 SHAK:医院和社区知识调查。
J Paediatr Child Health. 2022 Aug;58(8):1414-1419. doi: 10.1111/jpc.16007. Epub 2022 May 3.
9
Effectiveness of Evidence-Based Practice (EBP) Education on Emergency Nurses' EBP Attitudes, Knowledge, Self-Efficacy, Skills, and Behavior: A Randomized Controlled Trial.基于证据的实践(EBP)教育对急诊护士 EBP 态度、知识、自我效能、技能和行为的影响:一项随机对照试验。
Worldviews Evid Based Nurs. 2021 Feb;18(1):23-32. doi: 10.1111/wvn.12485. Epub 2021 Jan 25.
10
The attitude and knowledge of intensive care physicians and nurses regarding organ donation in Hungary--it needs to be changed.匈牙利重症监护医生和护士对器官捐赠的态度与知识——亟需改变。
Ann Transplant. 2012 Jul-Sep;17(3):93-102. doi: 10.12659/aot.883463.

引用本文的文献

1
Comparing pharmacists versus allergists in low-risk penicillin allergy delabelling: The Hong Kong Penicillin Allergy Pharmacist Initiative (HK-PAPI).低风险青霉素过敏解除标签认定中药剂师与过敏症专科医生的比较:香港青霉素过敏药剂师倡议(HK-PAPI)
World Allergy Organ J. 2024 Nov 21;17(12):101003. doi: 10.1016/j.waojou.2024.101003. eCollection 2024 Dec.
2
NSAID Allergy Labels Associated With Mortality and Cardiovascular Outcomes in Stroke.与卒中死亡率及心血管结局相关的非甾体抗炎药过敏标签
Stroke. 2025 Jan;56(1):30-38. doi: 10.1161/STROKEAHA.124.047921. Epub 2024 Nov 19.

本文引用的文献

1
Prospective, Multicenter, Head-to-Head Comparison Between Allergists Versus Nonallergists in Low-Risk Penicillin Allergy Delabeling: Effectiveness, Safety, and Quality of Life (HK-DADI2).前瞻性、多中心、过敏专科医生与非过敏专科医生在低风险青霉素过敏脱标签治疗中的头对头比较:有效性、安全性和生活质量(HK-DADI2)。
J Allergy Clin Immunol Pract. 2024 Jul;12(7):1801-1808.e2. doi: 10.1016/j.jaip.2024.04.010. Epub 2024 Apr 16.
2
Students' Perception of Online Versus Face-to-Face Learning: What Do the Healthcare Teachers Have to Know?学生对在线学习与面对面学习的认知:医护教师需要了解什么?
Cureus. 2024 Feb 14;16(2):e54217. doi: 10.7759/cureus.54217. eCollection 2024 Feb.
3
Identifying the most at-risk age-group and longitudinal trends of drug allergy labeling amongst 7.3 million individuals in Hong Kong.
识别香港730万人中药物过敏标签的最高风险年龄组和纵向趋势。
BMC Med. 2024 Jan 26;22(1):30. doi: 10.1186/s12916-024-03250-0.
4
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches.低风险青霉素过敏脱敏:直接口服激发试验实践、实施及多学科方法的范围综述
Expert Rev Anti Infect Ther. 2024 Jan-Jun;22(1-3):59-69. doi: 10.1080/14787210.2023.2296068. Epub 2024 Feb 12.
5
APAAACI clinical pathway on direct provocation testing for penicillin allergy delabeling.美国变态反应、哮喘与免疫学会临床实践指南:青霉素过敏标签去除的直接激发试验
Asia Pac Allergy. 2023 Dec;13(4):142-147. doi: 10.5415/apallergy.0000000000000122. Epub 2023 Oct 18.
6
Changing patterns in the epidemiology of drug allergy.药物过敏流行病学的变化模式。
Allergy. 2024 Mar;79(3):613-628. doi: 10.1111/all.15970. Epub 2023 Dec 12.
7
Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study.住院和门诊环境中青霉素过敏去标签化的障碍:一项定性研究
Allergy Asthma Clin Immunol. 2023 Oct 11;19(1):88. doi: 10.1186/s13223-023-00842-y.
8
Drug allergy knowledge, attitude, and practice: A survey among doctors and pharmacists in public health facilities of Sabah, Malaysia.药物过敏知识、态度及实践:马来西亚沙巴州公共卫生机构医生和药剂师的一项调查
Asia Pac Allergy. 2023 Sep;13(3):121-126. doi: 10.5415/apallergy.0000000000000115. Epub 2023 Sep 14.
9
Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trial.青霉素过敏状态及其对抗生素处方、患者结局和抗菌药物耐药性的影响(ALABAMA):一项多中心、平行臂、开放性标签、随机实用临床试验方案。
BMJ Open. 2023 Sep 4;13(9):e072253. doi: 10.1136/bmjopen-2023-072253.
10
Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial.临床决策规则在低风险青霉素过敏患者中直接口服激发试验的疗效:PALACE 随机临床试验。
JAMA Intern Med. 2023 Sep 1;183(9):944-952. doi: 10.1001/jamainternmed.2023.2986.